Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic F… (NCT06666894) | Clinical Trial Compass
CompletedNot Applicable
Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver Patients
Egypt40 participantsStarted 2022-01-01
Plain-language summary
This study was conducted to compare between the effect of intermittent fasting and diatery approach to stop hypertension on metabolic risk profile in nonalcoholic fatty liver patients.
Who can participate
Age range30 Years – 40 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Non-alcoholic fatty liver patients diagnosed by radiological ultrasound
* BMI \>30
* All patients are sedentary lifestyle with little or no exercise.
* High lipid profile (total cholesterol \> 200, LDL \> 130, TAGs \> 150) patients by laboratory investigation.
* High fasting insulin level \> 20mlU/mL \& high fasting Glucose level \>100, HbA1c \> 5.7 \& high HOMA- IR \> 2.5 patients by Laboratory investigation.
* High inflammatory markers (IL6) patients.
* Age ranged from 30 to 40 years old.
Exclusion Criteria:
* Alcoholic fatty liver patients.
* Cirrhosis patients.
* Diabetes patients.
* Cognitive impaired patients.
* History of epilepsy patients.
* Cardiac pacemaker patients.
* Anemic patients
* pregnancy
What they're measuring
1
assessment of Non-alcoholic fatty liver using ultrasonography